PL2396325T3 - Pochodne azaindoli jako inhibitory kinaz białkowych abl i src - Google Patents
Pochodne azaindoli jako inhibitory kinaz białkowych abl i srcInfo
- Publication number
- PL2396325T3 PL2396325T3 PL10710439T PL10710439T PL2396325T3 PL 2396325 T3 PL2396325 T3 PL 2396325T3 PL 10710439 T PL10710439 T PL 10710439T PL 10710439 T PL10710439 T PL 10710439T PL 2396325 T3 PL2396325 T3 PL 2396325T3
- Authority
- PL
- Poland
- Prior art keywords
- azaindoles
- src
- inhibitors
- derivatives
- protein kinases
- Prior art date
Links
- 102000001253 Protein Kinase Human genes 0.000 title 1
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 108060006633 protein kinase Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20227909P | 2009-02-12 | 2009-02-12 | |
| FR0900631A FR2941948B1 (fr) | 2009-02-12 | 2009-02-12 | Derives d'azaindoles en tant qu'inhibiteur des proteines kinases abl et src |
| EP10710439.0A EP2396325B1 (en) | 2009-02-12 | 2010-02-12 | Derivatives of azaindoles as inhibitors of protein kinases abl and src |
| PCT/IB2010/000593 WO2010092489A1 (en) | 2009-02-12 | 2010-02-12 | Derivatives of azaindoles as inhibitors of protein kinases abl and src |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2396325T3 true PL2396325T3 (pl) | 2015-10-30 |
Family
ID=40886859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10710439T PL2396325T3 (pl) | 2009-02-12 | 2010-02-12 | Pochodne azaindoli jako inhibitory kinaz białkowych abl i src |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8580815B2 (enExample) |
| EP (1) | EP2396325B1 (enExample) |
| JP (1) | JP5583698B2 (enExample) |
| AU (1) | AU2010212560B2 (enExample) |
| CA (1) | CA2751478A1 (enExample) |
| DK (1) | DK2396325T3 (enExample) |
| ES (1) | ES2540962T3 (enExample) |
| FR (1) | FR2941948B1 (enExample) |
| HR (1) | HRP20150697T8 (enExample) |
| HU (1) | HUE024989T2 (enExample) |
| PL (1) | PL2396325T3 (enExample) |
| PT (1) | PT2396325E (enExample) |
| SI (1) | SI2396325T1 (enExample) |
| SM (1) | SMT201500175B (enExample) |
| WO (1) | WO2010092489A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME03000B (me) * | 2012-12-21 | 2018-10-20 | Plexxikon Inc | Jedinjenja i metode modulacije kinaze i povezane indikacije |
| FR3000493A1 (fr) * | 2012-12-28 | 2014-07-04 | Oribase Pharma | Nouveaux inhibiteurs de proteines kinases |
| FR3000494B1 (fr) * | 2012-12-28 | 2015-08-21 | Oribase Pharma | Nouveaux derives d'azaindoles en tant qu'inhibiteurs de proteines kinases |
| FR3000492B1 (fr) * | 2012-12-28 | 2015-09-11 | Oribase Pharma | Nouveaux derives azaindole en tant qu'inhibiteurs multikinases |
| US10722484B2 (en) | 2016-03-09 | 2020-07-28 | K-Gen, Inc. | Methods of cancer treatment |
| MA49014A (fr) * | 2017-03-21 | 2020-02-05 | Arbutus Biopharma Corp | Dihydroindène-4-carboxamides substitués, leurs analogues et procédés d'utilisation correspondant |
| AU2021263383A1 (en) | 2020-04-29 | 2022-11-24 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
| CN111943947B (zh) * | 2020-07-24 | 2021-04-30 | 重庆文理学院 | 1H-吡咯[2,3-b]吡啶衍生物及其合成方法与应用 |
| CA3196620A1 (en) | 2020-10-05 | 2022-04-14 | Enliven Therapeutics, Inc. | 5- and 6-azaindole compounds for inhibition of bcr-abl tyrosine kinases |
| WO2022076973A1 (en) * | 2020-10-05 | 2022-04-14 | Enliven Therapeutics, Inc. | 7-azaindole compounds for inhibition of bcr-abl tyrosine kinases |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0330043D0 (en) * | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them |
| GB0330042D0 (en) | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them |
| TW200616632A (en) * | 2004-06-17 | 2006-06-01 | Plexxikon Inc | Compounds modulating c-kit activity and uses therefor |
| US7361764B2 (en) | 2004-07-27 | 2008-04-22 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
| NZ553267A (en) | 2004-07-27 | 2010-09-30 | Sgx Pharmaceuticals Inc | Pyrrolo-pyridine kinase modulators |
| US7709645B2 (en) | 2004-07-27 | 2010-05-04 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
| WO2006104971A1 (en) * | 2005-03-28 | 2006-10-05 | Bristol-Myers Squibb Company | Atp competitive kinase inhibitors |
| BRPI0716477A2 (pt) | 2006-09-06 | 2014-03-18 | Hoffmann La Roche | Derivados heteroarila como inibidores de quinase protéica |
| JP5244118B2 (ja) * | 2006-11-10 | 2013-07-24 | ブリストル−マイヤーズ スクイブ カンパニー | 新規キナーゼ阻害剤 |
| WO2008144253A1 (en) * | 2007-05-14 | 2008-11-27 | Irm Llc | Protein kinase inhibitors and methods for using thereof |
| WO2009111278A2 (en) * | 2008-02-29 | 2009-09-11 | Array Biopharma Inc. | Raf inhibitor compounds and methods of use thereof |
| HUE035798T2 (en) * | 2008-11-03 | 2018-05-28 | Syntarga Bv | CC-1065 analogues and conjugates |
-
2009
- 2009-02-12 FR FR0900631A patent/FR2941948B1/fr not_active Expired - Fee Related
-
2010
- 2010-02-12 HR HRP20150697TT patent/HRP20150697T8/hr unknown
- 2010-02-12 AU AU2010212560A patent/AU2010212560B2/en not_active Ceased
- 2010-02-12 EP EP10710439.0A patent/EP2396325B1/en not_active Not-in-force
- 2010-02-12 PT PT107104390T patent/PT2396325E/pt unknown
- 2010-02-12 JP JP2011549698A patent/JP5583698B2/ja not_active Expired - Fee Related
- 2010-02-12 US US13/148,988 patent/US8580815B2/en not_active Expired - Fee Related
- 2010-02-12 WO PCT/IB2010/000593 patent/WO2010092489A1/en not_active Ceased
- 2010-02-12 HU HUE10710439A patent/HUE024989T2/en unknown
- 2010-02-12 ES ES10710439.0T patent/ES2540962T3/es active Active
- 2010-02-12 DK DK10710439.0T patent/DK2396325T3/en active
- 2010-02-12 CA CA2751478A patent/CA2751478A1/en not_active Abandoned
- 2010-02-12 SI SI201030964T patent/SI2396325T1/sl unknown
- 2010-02-12 PL PL10710439T patent/PL2396325T3/pl unknown
-
2015
- 2015-07-22 SM SM201500175T patent/SMT201500175B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8580815B2 (en) | 2013-11-12 |
| ES2540962T3 (es) | 2015-07-15 |
| DK2396325T3 (en) | 2015-06-29 |
| EP2396325B1 (en) | 2015-04-01 |
| SI2396325T1 (sl) | 2015-08-31 |
| FR2941948A1 (fr) | 2010-08-13 |
| JP5583698B2 (ja) | 2014-09-03 |
| US20110312959A1 (en) | 2011-12-22 |
| PT2396325E (pt) | 2015-08-21 |
| AU2010212560B2 (en) | 2016-01-21 |
| FR2941948B1 (fr) | 2013-04-05 |
| HRP20150697T8 (xx) | 2015-11-06 |
| WO2010092489A1 (en) | 2010-08-19 |
| HRP20150697T1 (hr) | 2015-08-14 |
| AU2010212560A1 (en) | 2011-08-11 |
| JP2012517465A (ja) | 2012-08-02 |
| SMT201500175B (it) | 2015-09-07 |
| EP2396325A1 (en) | 2011-12-21 |
| CA2751478A1 (en) | 2010-08-19 |
| HUE024989T2 (en) | 2016-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2396325E (pt) | Derivados de azaindoles como inibidores das proteínacinases abl e src | |
| IL208719A0 (en) | Inhibitors of protein kinases | |
| IL221311A0 (en) | Inhibitors of protein kinases | |
| ZA201008962B (en) | Isoindolone derivatives as mek kinase inhibitors and methods of use | |
| IL210363A0 (en) | Kinase inhibitors and methods of use | |
| EP2252293A4 (en) | KINASEHEMMER AND USE PROCESS | |
| EP2445885A4 (en) | SUBSTITUTED HETEROCYCLIC COMPOUNDS AS CHINESE INHIBITORS AND METHOD FOR THEIR USE | |
| ZA201008961B (en) | Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases | |
| EP2539348A4 (en) | CEPHALOSPORIN DERIVATIVES AS BETA LACTAMASE HEMMER AND COMPOSITIONS THEREFOR AND METHOD FOR THEIR USE | |
| ZA201006128B (en) | Pim kinase inhibitors and methods of their use | |
| PL2504336T3 (pl) | Nowe pochodne naftyrydynowe i ich zastosowanie jako inhibitorów kinaz | |
| IL194699A0 (en) | Tetrahydropteridines useful as inhibitors of protein kinases | |
| ZA201202020B (en) | Compounds and compositions as protein kinase inhibitors | |
| ZA201108622B (en) | Pyrazolopyrimidines and related heterocycles as kinase inhibitors | |
| PL2470528T3 (pl) | Związki i kompozycje jako inhibitory kinazy białkowej | |
| ZA201204418B (en) | 2-arylimidazole derivatives as pde10a enzyme inhibitors | |
| IL236830A0 (en) | Diazahomoredene derivatives and methods of using them | |
| EP2323659A4 (en) | COMPOUNDS USEFUL AS INHIBITORS OF PROTEIN KINASES | |
| ZA200806871B (en) | Dihydrodiazepines useful as inhibitors of protein kinases | |
| EP2766356A4 (en) | QUINAZOLINE DERIVATIVES AS INHIBITORS OF KINASES AND METHODS OF USE THEREOF | |
| ZA201008026B (en) | Inhibitors of ikk-b serine-threonine protein kinase | |
| GB0907120D0 (en) | Inhibitors of IKK-ß serine-threonine protein kinase | |
| ZA201300009B (en) | Oral formulation of kinase inhibitors | |
| GB201003949D0 (en) | Inhibitors of protein kinases | |
| GB0719877D0 (en) | Inhibitors of protein kinases |